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ABSTRACT 
Objective: Pellionia heyneana Wedd. leaf has been used by the Cholanaikan tribe as a traditional medicine to enhance immunity and also to treat 
various liver ailments. However, no scientific reports are available regarding its long term toxicity studies. The objective of the present study was to 
investigate the chronic oral toxicity study of P. heyneana leaf. 
Methods: In the present study, scientific evaluation of oral toxicity of P. heyneana crude ethanolic leaf extract (PHLE) and leaf ethanolic fraction 
(PHEF) were carried out in Wistar rats. Animals were fed with three varying concentrations (500 mg/kg, 1000 mg/kg and 1500 mg/kg) of PHLE 
and PHEF for 90 d. During the study period, all the animals were closely observed for any morbidity or mortality, food and water intake, body 
weight etc. The effect of PHLE and PHEF on animal behaviour, metabolism, liver function, kidney function, blood glucose level, in vivo antioxidant 
status, haematological parameters, histopathology of internal organs etc. were evaluated after 90 d chronic toxicity study. 
Results: All the animals administered with PHLE/PHEF up to 1500 mg/kg dose did not show any deleterious changes in normal metabolism, 
histopathology of internal organs, haematological and biochemical indices. 
Conclusion: All these results revealed that PHLE and PHEF of P. heyneana are non toxic in long term oral administration in Wistar rats. 
Keywords: Pellionia heyneana, Chronic oral toxicity, Cholanaikan tribe, Histopathology  
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INTRODUCTION 
The pivotal role played by medicinal plants in ensuring the health 
care needs of humans have seen an upsurge in the last few decades. 
As has been pointed out by the WHO, about 80% of the world’s 
population rely predominantly on plants and plant extracts for 
health care [1]. In the present scenario, a large number of 
ethnomedicinal plants are used in the pharmaceutical industries for 
finding new therapeutic agents for the various fields of biomedicine 
[2]. 
P. heyneana Wedd. is an herb belonging to Urticaceae family, 
frequently growing in moist forests. Cholanaikans, the most 
primitive and one of the remaining hunter-gatherer tribes of South 
India call this plant as ‘Elaven’, and believe that the plant juice makes 
them young and energetic. They use the leaf juice of P. heyneana in 
their traditional medicine for treating immunodeficiency in children 
[4] and various liver diseases [5]. 
This is because of the widespread misconception that the plants 
used in traditional medicine are harmless and carry no risk for its 
use due to their natural origin. But as with all other medicines, the 
long term administration of certain herbal medicines may cause 
adverse effects both in humans and animals [3]. Hence a 
comprehensive toxicity study is imperative in order to establish its 
safety, efficacy and quality and also to ascertain the nontoxic nature 
of the medicinal plants used in traditional medicine. 
Even though the plant 
MATERIALS AND METHODS 
has 
significant medicinal property, no detailed toxicity study has been 
conducted so far, as regards the safe administration of the plant. 
Hence, the present studies have been carried out to evaluate the 
chronic oral toxicity of the plant. 
Chemicals and instruments 
All the chemicals for the study were purchased from Sigma Aldrich, 
USA. The biochemical kits were purchased from Coral Clinical 
System, Goa, India. Rotary evaporator (Buchi R-215, Switzerland) 
and auto hematology analyser-vet (Mindray China) were used. 
Collection and authentication of plant material 
P. heyneana Wedd. plants were collected from Kallar, 
Thiruvananthapuram district of Kerala, India, and authenticated by 
the plant taxonomist of the Institute. Voucher specimens were 
deposited at the Jawaharlal Nehru Tropical Botanic Garden and 
Research Institute Herbarium (TBGT 57060 dated 10/12/2010). 
Preparation of solvent extract/fractions  
The leaf powder of P. heyneana was extracted with 95% ethanol for 
48 h, using a soxhlet apparatus. The extract was then filtered and the 
filtrate was concentrated under reduced pressure using rotary 
evaporator, to get the crude extract (PHLE).  
For preparing serial fractions, P. heyneana leaf powder was first 
extracted with hexane using soxhlet apparatus, powder was then 
dried and again extracted with chloroform and finally with ethanol 
to get; hexane fraction (PHHF), chloroform fraction (PHCF) and 
ethanolic fraction (PHEF) respectively. 
Based on the antioxidant studies (data not shown), the most 
promising fractions namely PHLE and PHEF were selected for 
toxicological evaluation. 
Animals 
Wistar ♂ and ♀ rats (200-235 g) were obtained from the Institute’s 
Animal House. All the animals were housed in polypropylene cages 
under standard conditions with temperature 25±2 °C, relative 
humidity 60±10%, room air changes 15±3 times/h and a 12 h light-
dark cycles, fed commercial rat feed (Lipton India Ltd; Mumbai, 
India) and boiled water ad libitum. Animals were acclimatized for 1 
w before the initiation of the experiment. The study was carried out 
according to NIH guidelines after getting the approval of the 
Institute’s Animal Ethics Committee (No: B-19/11/2013/05C). 
Chronic toxicity study 
Wistar albino rats were divided into seven groups of 6 animals (3♂ 
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and 3♀/group) each. Group 1, the control group was treated with 
0.5% Tween-80 (vehicle) for 90 d. Groups II, III and IV were 
treated with PHLE extract 500, 1000 and 1500 mg/kg/d, p. o. and 
Groups V, VI and VII were treated with PHEF extract 500, 1000 
and 1500 mg/kg/d, p. o. respectively [6]. Toxic manifestations 
such as signs of toxicity, mortality and body weight changes were 
monitored daily. At the end of the study, all animals were fasted 
for 24 h and sacrificed by carbon dioxide inhalation on 91st day. 
Blood samples for haematological and biochemical analysis 
(estimation of plasma markers of hepatic injury, evaluation of 
kidney function, blood glucose level) were collected by cardiac 
puncture. Detailed gross necropsy, including careful examination 
of the body external surface, orifices and cranial, thoracic and 
abdominal cavities and their contents were performed in all the 
groups. Liver samples were subjected to antioxidant assays 
(estimation of malondialdehyde (MDA), assay of catalase (CAT), 
determination of reduced glutathione (GSH)). The internal organs 
(lungs, heart, liver, spleen and kidney) were collected, weighed 
and preserved in 10% formaldehyde solution for histopathological 
examination. 
Estimation of serum biochemical parameters of liver and kidney 
The collected blood was allowed to coagulate for 1h at room 
temperature. It was centrifuged at 1500 rpm for 15 min at 37 ºC to 
separate the serum. The serum was then subjected to the assay of 
hepatic marker enzymes, namely aspartate transaminase (AST), 
alanine transaminase (ALT), alkaline phosphatase (ALP), γ-glutamyl 
transferase (GGT) and other serum parameters namely, serum 
bilirubin (SB), total cholesterol (TC), triglycerides (TGL) and for 
evaluation of kidney function, estimation of urea and creatinine 
were carried out using the commercial kits by Coral clinical system, 
Goa, India. 
Estimation of blood glucose  
The blood glucose level is directly measured by placing one drop of 
blood on the test strip of blood glucometer and reading the values 
displayed. 
Estimation of liver malondialdehyde  
Malondialdehyde in the rat liver was estimated by the modified 
procedure [7]. Liver homogenate (10% w/v) from each group (1 ml) 
mixed with 100 µl of 8.1% SDS and 600 µl of 20% acetic acid 
solution was kept for 2 min at room temperature. Then 600 µl of 
0.8% solution of TBA was added, heated at 95 ºC for 60 min in a 
water bath and cooled with ice cold water at 4 ºC. A mixture of n-
butanol and pyridine (15:1 v/v) were added, shaken vigorously and 
centrifuged at 1 000 0 rpm for 5 min. The absorbance of the organic 
layer was measured at 532 nm. Lipid peroxidation was expressed as 
nmol/g wet liver. 
Assay of liver catalase 
Catalase in the rat liver was assayed according to the standard 
method [8]. To 0.9 ml of phosphate buffer (0.01M, pH-7.0) 0.1 ml 
of liver homogenate (10% w/v) and 0.4 ml of H2 O 2  (0.2 M) were 
added. After 60 sec, 2 ml of dichromate-acetic acid reagent (5%) 
was added. The tubes were kept in boiling water bath for 10 min 
and the colour developed was read at 620 nm. Standard H 2O 2  in 
the range of 2-10 µl was taken with blank containing reagent 
alone. CAT activity was measured proportionately to the rate of 
H 2O 2  reduction. Dichromate in acetic acid was converted to 
perchromic acid and then chromic acetate, when heated in the 
presence of H 2 O 2
Homogenized rat liver samples (10% w/v) from the entire group 
(0.2 ml) were mixed with 1.8 ml of 1 mM EDTA solution. To this, 3.0 
ml precipitating reagent (1.67 g of met phosphoric acid, 0.2 g of 
EDTA disodium salt, 30 g sodium chloride, 1000 ml distilled water) 
was added, mixed thoroughly and kept for 5 min before 
centrifugation. To 2 ml of the supernatant, 4.0 ml of 0.3 M disodium 
hydrogen phosphate solution and 1.0 ml of DTNB (5, 5’dithio-bis (2-
nitro benzoic acid)) reagent were added and absorbance was read at 
412 nm. Absorbance values were compared with a standard curve 
generated from the known GSH [10]. 
Haematological analysis 
Blood samples were collected in EDTA coated vials, mixed well and 
the haematological parameters namely, white blood cell (WBC) 
count, lymphocyte (LYM) count, monocyte (MONO) count, 
granulocyte (GRAN) count, LYM%, MONO%, GRAN%, red blood cell 
(RBC) count, hemoglobin (HGB) concentration, hematocrit (HCT) %, 
mean corpuscular volume (MCV), mean corpuscular hemoglobin 
concentration (MCHC), mean corpuscular hemoglobin (MCH), red 
blood cell distribution width (RDW), platelet (PLT) count, mean 
platelet volume (MPV), platelet distribution width (PDW) and 
platelet crit (PCT) % were estimated using veterinary auto 
hematology analyzer. 
Histopathological investigations 
A portion of the internal organ (liver, kidney, heart, lungs, spleen) 
obtained from all the groups were sliced into two pieces of 
approximately 6 mm
. Chromic acetate formed was measured at 620 
nm. Absorbance values were compared with a standard curve 
generated from known catalase and the activities were 
expressed as U/mg protein. The amount of protein/mg of tissue 
was determined by the standard method [9]. 
Determination of liver reduced glutathione 
3 size and preserved in 10% formalin solution 
for 24 h. They were subjected to dehydration with acetone of 
strength 70, 80 and 100 % respectively, each for 1 h. Infiltration and 
impregnation were done by treatment with paraffin wax, twice for 1 
h. Paraffin was used to prepare paraffin ‘L’ moulds. Specimens were 
cut into sections of 3-7 µm thickness and stained with haematoxylin 
and eosin. The thin sections of the liver were made into permanent 
slides and examined under high resolution microscope with 
photographic facility and photomicrographs were taken. 
Statistical analysis 
All the data were expressed as mean±standard deviation (SD). The 
significance of difference among the group was assessed using one 
way analysis of variance (ANOVA) followed by Dunnett’s post-test 
using SPSS software version-20. The p ≤ 0.05 was considered 
statistically significant. 
RESULTS 
Chronic toxicity study 
In chronic toxicity studies, PHEF and PHLE administration up to 
1500 mg/kg dose did not result in mortality or any change in 
behaviour of the animals.  
The drug treated animals did not show any decrease in body weight 
and they showed only a general increase in body weight (fig. 1). The 
mean increase in body weight within the group from the first day to 
the 90th
The detailed postmortem examination of the physical appearance of 
internal organs of all the doses of PHLE and PHEF treated animals 
did not show any macroscopic differences in size, color or texture 
compared to the normal control animals. 
 day of the experiment was; 135.45±8.75 g (NC), 
126.00±7.46 g (PHLE 500 mg/kg), 118.63±6.53 g (PHLE 1000 
mg/kg), 148.82±7.53 g (PHLE 1500 mg/kg), 170.43±5.34 g (PHEF 
500 mg/kg), 165.62±5.74g (PHEF 1000 mg/kg) and 164.47±6.41 g 
(PHEF 1500 mg/kg). The growth rate of each group was found to be 
1.51±0.08 g (NC), 1.40±0.08 g (PHLE 500 mg/kg), 1.32±0.07 g (PHLE 
1000 mg/kg), 1.65±0.08 g (PHLE 1500 mg/kg), 1.89±0. 06 g (PHEF 
500 mg/kg), 1.84±0.06 g (PHEF 1000 mg/kg) and 1.83±0.07 g 
(PHEF 1500 mg/kg). The mean organ body weight of internal organs 
like lungs, heart, liver, spleen and kidneys of all the experimental 
Wistar rats after 90 d toxicity study is represented in fig. 2. Internal 
organ weight relative to 100 g body weight of all the drugs treated 
animals, showed no significant (p ≤ 0.05) difference from the normal 
control values. No significant change in food and water intake of the 
test animals were observed at all the test doses compared to the 
normal control.  
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Fig. 1: Effect of PHLE and PHEF in body weight of Wistar rats in chronic toxicity study 
 
 
Fig. 2: Effect of PHLE and PHEF on internal organ weight of Wistar rats after chronic toxicity study 
Values are expressed as mean±SD of six values, one way ANOVA followed by Dunnett’s multiple comparison test, ns
 
Estimation of serum biochemical parameters of liver and 
kidney 
Effect of PHLE and PHEF on serum hepatic marker enzymes, namely 
AST, ALT, ALP, GGT and other serum parameters namely, SB, TC, TP 
and TGL after the 90 d toxicity study are represented in table 1. All 
the parameters showed normal values and there was no significant 
(p ≤ 0.05) difference in the drug treated groups when compared to 
the normal control group. 
-no significant difference when 
compared to normal control 
Renal function was evaluated by estimating the urea and creatinine 
values in the serum. Urea and creatinine values of all doses of PHLE 
and PHEF treated animals together with the normal control values 
were shown in table 1. There was no significant (p ≤ 0.05) difference 
observed in the serum urea and creatinine values of drug treated 
animals when compared to normal control animals. The maximum 
value of urea found in the drug treated animals were 41.32±1.65 
mg/dl (PHLE 1500 mg/kg) and minimal value was 36.56±1.45 
mg/dl (PHLE 1000 mg/kg), whereas the normal control value was 
found to be 37.82±1.34 mg/dl. All the creatinine values were found 
to be within the range of 0.42±0.02 to 0.44±0.06 mg/dl. 
Estimation of blood glucose  
The blood glucose level of all the animals was found to be within the 
normal range. There was no significant change in the glucose levels 
of animals treated with all the doses of PHLE and PHEF when 
compared with normal control animals (table 1). 
 
Table 1: Effect of PHLE and PHEF on serum biochemical parameters in chronic toxicity study 
Parameters Treatment groups 












AST (IU/l) 65.36±3.47 68.12±2.87 65.47±3.82ns 73.65±3.47ns 65.87±2.47ns 71.83±3.61ns 71.65±3.21ns ns 
ALT (IU/l) 40.39±1.45 43.78±1.67 46.65±1.28ns 49.85±1.84ns 46.57±1.87ns 48.69±1.86ns 49.63±1.35ns 
ALP (IU/l) 
ns 
91.36±3.19 94.54±1.34 96.87±1.43ns 94.54±1.96ns 90.36±2.69ns 98.12±1.58ns 100.79±1.47ns 
GGT (IU/l) 
ns 
7.13±1.34 6.45±1.40 7.82±1.34ns 7.72±1.86ns 6.11±1.25ns 6.86±1.57ns 7.13±1.65ns 
SB (mg/dl) 
ns 
0.38±0.04 0.39±0.04 0.36±0.05ns 0.42±0.01ns 0.34±0.04ns 0.39±0.05ns 0.46±0.06ns 
TC (mg/dl) 
ns 
99.65±3.32 96.62±2.54 98.62±2.37ns 97.88±2.54ns 93.61±2.67ns 99.88±2.54ns 103.57±3.48ns 
TP (g/dl) 
ns 
5.70±0.25 5.96±0.31 5.86±0.34ns 5.13±0.36ns 5.12±0.31ns 4.93±0.31ns 4.68±0.36ns 
TGL (mg/dl) 
ns 
95.33±2.67 98.13±3.88 97.43±2.64ns 99.65±1.34ns 91.37±3.45ns 102.68±3.43ns 123.69±3.6ns 
Glucose (mg/dl) 
ns 
121.23±4.23 112.45±4.61 118.65±4.51ns 111.56±4.54ns 118.46±4.61ns 119.68±4.62ns 121.43±5.2ns 
Urea (mg/dl) 
ns 
37.82±1.34 40.84±1.32 36.56±1.45ns 41.32±1.65ns 36.56±1.75ns 37.35±1.63ns 40.56±1.42ns 
Creatinine (mg/dl) 
ns 
0.42±0.06 0.43±0.05 0.42±0.03ns 0.44±0.06ns 0.43±0.04ns 0.43±0.02ns 0.42±0.02ns ns 
Values are expressed as mean±SD, n = 6, one way ANOVA followed by Dunnett’s multiple comparison test, ns-no significant difference when 
compared to normal control. 
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Evaluation of in vivo antioxidant status of liver 
MDA, CAT and GSH of the liver in the entire plant drug treated 
groups showed no significant difference from the normal control 
group at 90 d chronic toxicity study (fig. 3-5). PHLE and PHEF up to 
1500 mg/kg did not show any negative impact on the in vivo 
antioxidant status of the liver. 
 
 
Fig. 3: Effect of PHLE and PHEF on hepatic MDA after chronic toxicity study 
Values are expressed as mean±SD of six values, one way ANOVA followed by Dunnett’s multiple comparison test, nsˍ
 
 no significant difference when 
compared to normal control  
 
Fig. 4: Effect of PHLE and PHEF on hepatic CAT after chronic toxicity study 
Values are expressed as mean±SD of six values, one way ANOVA followed by Dunnett’s multiple comparison test, nsˍ
 
 no significant difference when 
compared to normal control 
 
Fig. 5: Effect of PHLE and PHEF on hepatic GSH after chronic toxicity study 
Values are expressed as mean±SD of six values, one way ANOVA followed by Dunnett’s multiple comparison test, nsˍ no significant difference when 
compared to normal control 
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Haematological analysis 
The haematological analysis report of blood samples of drug treated 
animals after 90 d of PHLE and PHEF administration is represented 
in table 2 and table 3 respectively. The eighteen haematological 
parameters of all the plant drug treated groups showed no 
significant difference (p ≤ 0.05) from the normal control values. 
There were no significant changes in RBC, WBC, granulocytes, 
lymphocytes, monocyte, platelet count etc. up to 1500 mg/kg of 
PHLE and PHEF treated animals. 
 
Table 2: Effect of P. heyneana leaf ethanolic extract on haematological parameters in chronic toxicity study 
Hematological parameters Groups 
Normal control PHLE 500 (mg/kg) PHLE 1000 (mg/kg) PHLE 1500 (mg/kg) 
WBC (×103 11.00±1.20 /µl) 13.40±2.34 14.00±2.00ns 16.10±1.20ns ns 
LYM (×103 7.40±0.45 /µl) 10.30±1.45 10.20±1.75ns 6.70±0.24ns 
MONO (×10
ns 
3 0.30±0.04 /µl) 0.30±0.06 0.30±0.01ns 2.50±0.12ns 
GRAN (×10
ns 
3 3.30±0.54 /µl) 2.80±0.30 3.50±0.09ns 6.90±0.45ns 
LYM% 
ns 
67.40±2.30 76.50±2.10 72.80±2.50ns 61.40±3.22ns 
MONO% 
ns 
3.00±0.45 2.50±0.45 2.50±0.14ns 5.70±1.54ns 
GRAN% 
ns 
29.60±1.28 21.00±1.50 24.70±2.15ns 32.90±2.46ns 
RBC (×10
ns 
6 9.00±0.34 /µl) 9.07±0.34 8.29±0.43ns 9.06±0.34ns 
HGB (g/dl) 
ns 
15.20±1.20 15.90±1.24 15.70±0.98ns 16.70±1.23ns 
HCT (%) 
ns 
47.50±2.40 48.40±1.78 47.90±1.50ns 51.00±1.94ns 
MCV (fl) 
ns 
52.80±2.75 53.40±1.29 57.90±2.30ns 56.30±2.45ns 
MCHC (g/dl) 
ns 
16.80±1.73 17.50±1.20 18.90±2.56ns 18.40±1.2ns 
MCH (pg) 
ns 
32.00±2.64 32.80±1.56 32.70±3.45ns 32.70±3.59ns 
RDW (%) 
ns 
15.30±1.63 15.00±1.46 17.80±1.74ns 9.80±1.40ns 
PLT (×10
ns 
3 1078.00±28.53 /µl) 1112.00±12.50 999.00±23.57ns 1030.00±42.34ns 
MPV (fl) 
ns 
5.30±0.10 5.300±0.20 6.10±0.63ns 5.80±0.10ns 
PDW 
ns 
16.20±2.59 16.20±1.67 17.00±2.64ns 16.70±2.84ns 
PCT (%) 
ns 
0.57±0.04 0.59±0.03 0.61±0.03ns 0.59±0.04ns ns 
Values are expressed as mean±SD, n = 6, one way ANOVA followed by Dunnett’s multiple comparison test, ns
 
-no significant difference when 
compared to normal control. 
Table 3: Effect of P. heyneana leaf ethanolic fraction on haematological parameters in chronic toxicity study 
Hematological parameters Groups 
Normal control PHEF 500 (mg/kg) PHEF 1000 (mg/kg) PHEF 1500 (mg/kg) 
WBC (×103 11.00±1.20 /µl) 12.38±2.13 13.89±2.28ns 15.91±1.20ns ns 
LYM (×103 7.40±0.45 /µl) 9.13±1.5 10.14±1.64ns 10.93±0.32ns 
MONO (×10
ns 
3 0.30±0.04 /µl) 0.34±0.05 0.31±0.03ns 0.50±0.12ns 
GRAN (×10
ns 
3 3.30±0.54 /µl) 2.91±0.2 3.44±0.06ns 3.48±0.41ns 
LYM% 
ns 
67.40±2.30 73.75±2.14 73.00±2.43ns 56.12±3.21ns 
MONO% 
ns 
3.00±0.45 2.75±0.38 2.23±0.16ns 3.14±1.62ns 
GRAN% 
ns 
29.60±1.28 23.51±1.47 24.77±2.47ns 21.87±2.51ns 
RBC (×10
ns 
6 9.00±0.34 /µl) 9.42±0.43 8.68±0.52ns 9.25±0.43ns 
HGB (g/dl) 
ns 
15.20±1.20 16.82±1.32 15.43±0.86ns 16.55±1.28ns 
HCT (%) 
ns 
47.50±2.4 49.34±1.65 47.67±1.48ns 50.36±1.83ns 
MCV (fl) 
ns 
52.80±2.75 53.65±1.34 55.37±2.54ns 56.37±2.17ns 
MCHC (g/dl) 
ns 
16.80±1.73 16.98±1.23 18.65±2.23ns 18.17±1.59ns 
MCH (pg) 
ns 
32.00±2.64 32.54±1.43 33.63±3.12ns 32.74±3.43ns 
RDW (%) 
ns 
15.30±1.63 15.81±1.27 17.15±1.15ns 14.61±1.63ns 
PLT (×10
ns 
3 1078.00±28.53 /µl) 1169.58±14.69 995.98±21.86ns 1189.45±47.32ns 
MPV (fl) 
ns 
5.30±0.10 5.88±1.28 6.46±1.54ns 5.72±2.83ns 
PDW 
ns 
16.20±2.59 15.65±1.45 16.76±2.45ns 16.43±2.13ns 
PCT (%) 
ns 
0.57±0.04 0.58±0.02 0.62±0.04ns 0.58±.03ns ns 
Values are expressed as mean±SD, n = 6, one way ANOVA followed by Dunnett’s multiple comparison test, ns
 
-no significant difference when 
compared to normal control. 
Histopathological investigations 
Histopathological examination of liver, heart, kidney, lungs and spleen 
of all the drugs treated animals showed normal architecture similar to 
the normal control group (fig. 6). Liver sections were normal with 
hepatic lobules consisting of branching and anastomosing plates of 
hepatic cells with clear sinusoidal space (fig. 6A). Abnormalities like 
necrotic or fatty changes were completely absent and Kupffer cells 
were less in number in all the liver sections examined. The 
interlobular septa with the portal area consisting of branches of portal 
veins and hepatic arteries are also visible and clearly demarcated.  
Microphotographs of the heart showed the normal architecture with 
normal muscle fibers. Abnormalities such as enlargement or 
disaggregation of connective tissues, interfibrillar hemorrhages, 
congestion and focal areas of disrupted cardiac muscle fibers were 
absent in all the drug treated groups. Focal areas of infiltration and 
significant lesions of pathological importance were completely absent 
(fig. 6B). 
Microscopic examination of the kidney showed normal renal 
cytoarchitecture with normal renal corpuscles and renal tubules 
which are surrounded by basement membrane. The glomeruli and 
Bowman's capsule appeared normal. The glomerular epithelium and 
the capsular space also appeared normal in the control and the treated 
groups (fig. 6C). Section of the medullary areas also exhibited normal 
collection of papillary ducts and ducts of Loops of Henle. 
Lung sections showed the cells lining the alveoli and the surrounding 
capillaries are normal, one cell thick, and are in very close contact with 
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each other to facilitate gas diffusion and no prominent thickening of 
the alveolar wall has been observed (fig. 6D).  
Splenic sections of all the drug treated animals showed normal 
cytoarchitecture comparable to the normal spleen. Areas of red and 
white pulp along with central arteries were observed. The germinal 
centers were also visible along with the connective tissue trabeculae 
and all appeared normal for both control group as well as for the 
treated groups (fig. 6E) 
 
 
Fig. 6: Effects of PHLE and PHEF on various rat organ histomorphologies in chronic oral toxicity study 
 
DISCUSSION 
Chronic toxicity studies will help to assess the undesirable effects of 
continuous or repeated exposure of plant extracts or compounds over a 
portion of the average life span of experimental animals, such as rodents. 
Specifically, they provide information on target organ toxicity and are 
designed to identify unobservable adverse effect levels [11]. In the 
present study, administration of PHLE and PHEF up to 1500 mg/kg for 
90 d did not show any clinical signs of toxicity or mortality in either sex. 
Changes in body weight serve as a sensitive indicator of the general 
health status of animals [12]. The gradual increment in body weight 
shown by the entire drug treated animals has been found to be 
statistically insignificant from the normal control values. All these 
evaluations confirmed that the PHLE and PHEF or their secondary 
metabolites had played no adverse role in the normal metabolism of the 
Wistar rats. Furthermore, the diet and water were well-accepted by the 
rats treated with PHLE and PHEF and this points out the fact that the 
drugs did not possibly cause any alterations in carbohydrate, protein or 
fat metabolism in these experimental animals as has been stressed by 
Klaassen [13]. 
The liver is the target site for most of the toxic metabolism, which 
may lead to the damage of membrane permeability of this organ and 
the leakage of liver enzymes into the blood stream [14]. Hence 
quantification of liver marker enzymes in animal system is one of 
the most frequent approaches adopted to evaluate the toxicity of a 
plant extract [15]. 
Estimation of biochemical parameters pertaining to kidney functions 
viz., urea and creatinine supports the nontoxic effects of the extracts 
on kidney functions. Since, almost all drugs, chemicals and 
xenobiotics are eliminated through renal excretion, a comprehensive 
study on the effect of the plant extract on kidney function is essential 
in the toxicity studies [17]. An increase in the levels of urea and 
creatinine are significant indicators of the damaged functional 
nephrons [18]. The results of serum biochemical parameters related 
to kidney functions viz. urea and creatinine had demonstrated no 
significant differences with respect to control group animals and the 
same shows nontoxic effect of P. heyneana on kidney function. 
The serum biochemical parameters were 
evaluated to understand the possible alterations in hepatic function 
influenced by the extracts. The nonsignificant changes in AST, ALT, 
ALP, GGT, TC, TP and SB values in the drug treated rats suggested 
that chronic administration of PHLE and PHEF is non-hepatotoxic 
even at higher doses (up to 1500 mg/kg). The non-significant 
change in the levels of AST and ALT also points out that the drugs 
have no toxic effect on heart tissue [16].  
Normal glucose level in the blood is maintained by the combined 
action of two hormones, namely glucagon and insulin, produced by 
hypothalamus and pancreas respectively. Any type of toxicity in 
these organs will interfere with the normal secretion of this 
hormone and alter the normal glucose level in the blood. Normal 
glucose level shown by the entire drug treated groups in the present 
study confirms that PHLE and PHEF had no adverse influence in 
maintaining normal glucose level in blood. 
MDA is one of the end products in lipid peroxidation and its 
increased level in liver indicates the hepatic damage. Reduced 
glutathione is an intracellular non-enzymatic antioxidant, which 
protects cells against free radicals, peroxides and other toxic 
compounds [19]. Catalase is an antioxidant enzyme present in all 
major organs, especially in the liver, which promotes the conversion 
of hydrogen peroxide into molecular oxygen and water without the 
production of free radicals [20]. Estimation of MDA, GSH and CAT in 
the liver of drug treated animals reflected no changes and all the 
antioxidant parameters were found to be remain within the normal 
range. All these findings imply the maintenance of normal hepatic 
non-enzymatic and enzymatic antioxidant mechanisms during PHLE 
and PHEF treatment. 
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The haematopoietic system is one of the most sensitive targets of 
toxic compounds and is an important index of physiological and 
pathological status in man and animals [21]. Furthermore, 
haematological analysis is relevant in risk evaluation as changes in 
the haematological system have higher predictive value for human 
toxicity when the data are translated from animal studies [22]. After 
90 d of treatment, there were no significant treatment-related 
changes in all the eighteen haematological parameters between 
control and treated groups. The non-significant effect of the extract 
on RBC count, HGB concentration, HCT %, MCV, MCHC, MCH and 
RDW indicates that PHLE and PHEF do not affect the erythropoiesis, 
morphology or osmotic fragility of the red blood cells [23]. White 
blood cells are the first line of cellular defense that respond to 
infectious agents, tissue injury, or inflammatory process. No 
significant changes were observed in the lymphocyte, monocyte and 
granulocyte count in drug treated groups, which further confirmed 
the above findings. All these normal haematological profiles of PHLE 
and PHEF treated groups justified the non-toxic nature of P. 
heyneana extract and fraction. 
The internal organs are highly sensitive to toxic drugs and the 
resultant hypertrophy of these organs provides the firsthand 
indication of toxicity which may be useful in predicting toxicity level, 
enzyme induction, physiologic perturbations and acute injury [24]. 
The lungs, heart, liver, spleen and kidney weight of the Wistar rats in 
the drug treated groups have compared favorably with those of the 
controls at all the doses of PHLE and PHEF investigated. The autopsy 
also revealed that there were no treatment related changes in both 
control and treated groups. No hypertrophy of organs was observed in 
this study amongst all the groups studied. In addition, the microscopic 
examination revealed that none of the organs from the extract treated 
rats showed any alteration in cell structure or any unfavorable effects. 
No pathologies were recorded in the histological sections of the vital 
organs (heart, liver, spleen, kidney and lungs) of the control group. 
These results revealed that the extract did not affect the secretory 
ability of the organs and is supported by the previous observations 
[25]. It is also possible that the extract did not cause any cellular 
constriction or inflammation of the organs which would have resulted 
in swelling and increase in weight. This finding is well corroborated by 
the histological findings which did not show any pathological changes 
in the lungs, heart, liver, spleen and kidney of the treated animals. 
CONCLUSION 
Based on above findings, it is clear that the experimental animals did 
not show any deleterious changes in organ, haematological and 
biochemical indices during the course of repeated administration of 
PHLE and PHEF and no mortality was observed during the period. On 
the basis of findings that emerged from the present investigation, it 
can be established that P. heyneana has no toxic effect on chronic oral 
administration in rodents and supports the tribal use of the plant in 
the traditional system of Kerala. Taking into consideration all the 
above facts, it can be very well judged that both extracts did not affect 
the major biochemical functions in the body of Wistar rats during the 
90 d toxicity study. Therefore, it is confirmed that the prolonged oral 
administration of PHLE and PHEF is safe without any toxic effect. 
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